Clearmind Medicine partners with Polyrizon for intranasal MEAI formulation

Go back to Clearmind Medicine partners with Polyrizon for intranasal MEAI formulation
(NASDAQ: CMND) Delayed: 5.97 --0 (-0%)
Previous Close $5.97    52 Week High $ 
Open $5.97    52 Week Low $ 
Day High $5.97    P/E N/A 
Day Low $5.97    EPS $ 
Volume 449       

(NASDAQ: PLRZ) Delayed: 8.58 --0 (-0%)
Previous Close $8.58    52 Week High $ 
Open $8.58    52 Week Low $ 
Day High $8.58    P/E N/A 
Day Low $8.58    EPS $ 
Volume 12